Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  329 results for ""Proto-Oncogene Proteins c-akt""

Your Filters

Publisher : springer verlag
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Silencing CXCL16 alleviate neuroinflammation and M1 microglial polarization in mouse brain hemorrhage model and BV2 cell model through PI3K/AKT pathway.

  • Authors : Dingyi L; Neurosurgery Center, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, People's Republic of China.; Libin H

Subjects: Chemokine CXCL16*/Chemokine CXCL16*/Chemokine CXCL16*/metabolism ; Microglia*/Microglia*/Microglia*/metabolism ; Microglia*/Microglia*/Microglia*/drug effects

  • Source: Experimental brain research [Exp Brain Res] 2024 Aug; Vol. 242 (8), pp. 1917-1932. Date of Electronic Publication: 2024 Jun 19.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0043312 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

TLQP-21 facilitates diabetic wound healing by inducing angiogenesis through alleviating high glucose-induced injuries on endothelial progenitor cells.

  • Authors : Fang Y; Laboratory Medicine Center, Department of Clinical Laboratory, Affiliated People's Hospital, Zhejiang Provincial People's Hospital, Hangzhou Medical College, No. 158, Shangtang Road, Gongshu District, Hangzhou Zhejiang, 310053, China.; Zhu Y

Subjects: Endothelial Progenitor Cells*/Endothelial Progenitor Cells*/Endothelial Progenitor Cells*/drug effects ; Endothelial Progenitor Cells*/Endothelial Progenitor Cells*/Endothelial Progenitor Cells*/metabolism ; Wound Healing*/Wound Healing*/Wound Healing*/drug effects

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Jul; Vol. 397 (7), pp. 4993-5004. Date of Electronic Publication: 2024 Jan 06.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Paeonol upregulates expression of tumor suppressors TNNC1 and SCARA5, exerting anti-tumor activity in non-small cell lung cancer cells.

  • Authors : Zhang C; Department of Thoracic Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121001, China.; Zhang J

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Jul; Vol. 397 (7), pp. 5241-5251. Date of Electronic Publication: 2024 Jan 24.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Quercetin influences intestinal dysbacteriosis and delays alveolar epithelial cell senescence by regulating PTEN/PI3K/AKT signaling in pulmonary fibrosis.

  • Authors : Wu W; Department of Geriatric Medicine, Henan Provincial People's Hospital, Zhengzhou University, Jinshui District, No. 7 Weiwu Road, Zhengzhou, 450000, Henan, China. .; Wu X

Subjects: Quercetin*/Quercetin*/Quercetin*/pharmacology ; Cellular Senescence*/Cellular Senescence*/Cellular Senescence*/drug effects ; Proto-Oncogene Proteins c-akt*/Proto-Oncogene Proteins c-akt*/Proto-Oncogene Proteins c-akt*/metabolism

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Jul; Vol. 397 (7), pp. 4809-4822. Date of Electronic Publication: 2023 Dec 28.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Enhancement of cardiac angiogenesis in a myocardial infarction rat model using selenium alone and in combination with PTXF: the role of Akt/HIF-1α signaling pathway.

  • Authors : Elseweidy MM; Biochemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt. .; Ali SI

Subjects: Hypoxia-Inducible Factor 1, alpha Subunit*/Hypoxia-Inducible Factor 1, alpha Subunit*/Hypoxia-Inducible Factor 1, alpha Subunit*/metabolism ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/drug therapy ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/pathology

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Jul; Vol. 397 (7), pp. 4677-4692. Date of Electronic Publication: 2023 Dec 19.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

A first-in-human phase I study of TAS-117, an allosteric AKT inhibitor, in patients with advanced solid tumors.

  • Authors : Doi T; National Cancer Center Hospital East, Kashiwa, Japan. .; Takahashi S

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/pathology ; Proto-Oncogene Proteins c-akt*/Proto-Oncogene Proteins c-akt*/Proto-Oncogene Proteins c-akt*/antagonists & inhibitors

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Jun; Vol. 93 (6), pp. 605-616. Date of Electronic Publication: 2024 Feb 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

RETRACTED ARTICLE: Investigating EGFR-VEGF-mediated apoptotic effect of cucurbitacin D and I combination with sorafenib via Ras/Raf/MEK/ERK and PI3K/Akt signaling pathways.

  • Authors : Üremis N; Department of Medical Biochemistry, Medical Faculty, Inonu University, Malatya, Turkey. .; Türköz Y

Subjects: Sorafenib*/Sorafenib*/Sorafenib*/pharmacology ; Sorafenib*/Sorafenib*/Sorafenib*/administration & dosage ; Proto-Oncogene Proteins c-akt*/Proto-Oncogene Proteins c-akt*/Proto-Oncogene Proteins c-akt*/metabolism

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 May; Vol. 397 (5), pp. 3247. Date of Electronic Publication: 2023 Nov 02.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Micafungin exerts antitumor effect on breast cancer and osteosarcoma through preventing EMT in tumor cells in an USP7/AKT/GSK-3β pathway-dependent manner.

  • Authors : Wang QL; Department of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.; Department of Laboratory Medicine, Changsha Blood Central, Changsha, 410005, China.

Subjects: Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/drug therapy ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/pathology ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/metabolism

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Jun; Vol. 397 (6), pp. 4447-4459. Date of Electronic Publication: 2023 Dec 18.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Licochalcone A alleviates ferroptosis in doxorubicin-induced cardiotoxicity via the PI3K/AKT/MDM2/p53 pathway.

  • Authors : Chen G; Department of Cardiology, Affiliated Nanping First Hospital, Fujian Medical University, Nanping, Fujian, China.; Luo S

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; Doxorubicin*/Doxorubicin*/Doxorubicin*/toxicity ; Chalcones*/Chalcones*/Chalcones*/pharmacology

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Jun; Vol. 397 (6), pp. 4247-4262. Date of Electronic Publication: 2023 Dec 11.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Investigating the role of let-7a microRNA in cisplatin sensitivity of A549 lung cancer cells.

  • Authors : Aslan ES; Molecular Biology and Genetics Department, Faculty of Engineering and Natural Sciences, Biruni University, Merkezefendi, 75 Sk No:1-13 M. G, 34015, Zeytinburnu, İstanbul, Turkey. .; Aydin E

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/pharmacology ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Jun; Vol. 397 (6), pp. 3979-3984. Date of Electronic Publication: 2023 Nov 22.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  329 results for ""Proto-Oncogene Proteins c-akt""